These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7428646)

  • 1. [Fendiline and isosorbide dinitrate in coronary heart disease (author's transl)].
    Schäfer N; Belz GG; Stauch M; Schneider B
    Dtsch Med Wochenschr; 1980 Sep; 105(36):1253-8. PubMed ID: 7428646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dose-effect relationship of isosorbide dinitrate in the treatment of angina pectoris (author's transl)].
    Schneider W; Stahl B; Kaltenbach M; Bussmann WD
    Dtsch Med Wochenschr; 1982 May; 107(20):771-6. PubMed ID: 7075499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
    Reiniger G; Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of isosorbide dinitrate and nifedipine in the treatment of variant angina pectoris. Randomized study].
    Aschermann M; Bultas J; Karetová D; Kölbel F; Simper D; Kozáková M
    Cas Lek Cesk; 1989 Sep; 128(37):1178-81. PubMed ID: 2805034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.
    Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
    Z Kardiol; 1983; 72 Suppl 3():259-67. PubMed ID: 6666231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
    Parker JO; Baird MG
    Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The anti-ischemic effect of isosorbide dinitrate alone and in combination with gallopamil and propranolol].
    Sthler-Klich HM; Hopf R; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 2():179-82; discussion 188-9. PubMed ID: 2686258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
    Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
    Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance development during isosorbide dinitrate treatment: can it be circumvented?
    Rudolph W; Blasini R; Reiniger G; Brügmann U
    Z Kardiol; 1983; 72 Suppl 3():195-8. PubMed ID: 6421009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment and tolerance with high doses of isosorbide dinitrate in a slow release form in patients with angina pectoris.
    Becker HJ; Fach WA; Weil J; Hüwer HD
    Z Kardiol; 1983; 72 Suppl 3():199-202. PubMed ID: 6666222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antianginal efficacy of long-term nitrate therapy.
    Kenedi P; Giebeler B
    Z Kardiol; 1983; 72 Suppl 3():233-8. PubMed ID: 6666227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
    Vogler AC; Silber S; Spiegelsberger F; Theisen K
    Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cycloergometric evaluation of fendiline in chronic coronary insufficiency].
    Armaganijan D; Batlouni M; de Araújo JR
    Arq Bras Cardiol; 1979 Sep; 33(3):225-8. PubMed ID: 396912
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate].
    Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
    G Ital Cardiol; 1986 Nov; 16(11):895-903. PubMed ID: 3104123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R; Brügmann U; Reiniger G; Rudolph W
    Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ischemic heart disease with beta-receptor blockers and isosorbide dinitrate (author's transl)].
    Wermuth G
    MMW Munch Med Wochenschr; 1975 Oct; 117(40):1613-4. PubMed ID: 241932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.